Can you provide the approval date for apotex's ruxolitinib?

Do you mean the FDA approval date for Apotex’s generic ruxolitinib (US), or the original approval of ruxolitinib (brand name Jakafi) in general? Also, do you want the date for a specific jurisdiction (US, Canada, EU, etc.)?

What I can share now:
- The original ruxolitinib product (Jakafi) was approved by the FDA on November 15, 2011 for myelofibrosis.
- I don’t have a confirmed record that Apotex has an approved generic ruxolitinib in the US. If you want the exact status and date for Apotex’s product in a specific market, I can look it up if you’d like me to check current regulatory databases.

If you can confirm the jurisdiction (US, Canada, EU) and whether you want the generic approval date or the original drug’s date, I’ll provide the precise info.